This Cancer Drug Is So Effective, The FDA Approved It Immediately
June 11, 2017
A new cancer drug has overwhelmingly helped shrink or eradicate tumors in patients whose cancer had resisted every other form of treatment.
The results, published in the journal Science, are so striking that the Food and Drug Administration already has approved the drug.
Image credit: Merck
The study followed 86 cancer patients with tumors of the pancreas, prostate, uterus or bone. Each patient was given pembrolizumab, which also goes by the brand name Keytruda.
After taking the drug, 66 patients had their tumors shrink substantially and stabilize, instead of continuing to grow. Among them were 18 patients whose tumors vanished and have not returned.
According to the New York Times, this is the first time a drug has been approved for use against tumors that share a particular genetic profile, regardless of where they appear in the body.
Dr. Jack Jacoub, a medical oncologist and director of thoracic oncology at Memorial Care Cancer Institute at Orange Coast Memorial Medical Center, said "The FDA doesn't take these kinds of things lightly. The data was so good, they had to approve it."
Click Here For The Most Popular On Sunny Skyz
Couple Rescues Prairie Dog From Their Dog's Mouth, Then Decides To Adopt It
Ohio Man Makes Waves With His Fully Functioning Hot Dog Boat
Stunning Footage Captures Moment Mount Lewotobi Erupts, Sending Ash Nearly 7 Miles High
Teacher’s Final Wish: Backpacks For Students In Need Fill The Aisles At Her Funeral
Why Hope Is The Key To A Meaningful Life, Backed By New Research
Judge Waives Parking Fines So Dad Can Keep Supporting Son’s Space Dreams
Every Day, This Golden Retriever Leaps Into The Pig Pen To Play With The Piglets
Dog Saves His Best Friend's Life In Incredible Moment Caught On Video
Newborn Baby Has Sweet Conversation With Dad While Lying On Mom’s Face
Woman Tries To Help Bird, Then This Happened... And We Can't Stop Laughing
Blown Away: Cat Covers Face And Gasps In Adorable Overreaction